Clinical Trial Update: A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating IV/PO moxifloxacin for complicated skin and skin structure infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Skin Structure Infections

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Bayer | Conditions: Infectious Diseases | Phase 3 | Status: COMPLETED